v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (2,964,691) $ (3,466,282)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 863 863
Stock-based compensation 236,491 478,193
Changes in operating assets and liabilities:    
Accrued revenue (215,385) 0
Prepaid expenses and other assets (144,036) (117,240)
Investments 0 (58,335)
Accounts payable 1,794 (254,141)
Accrued expenses (122,364) 161,766
Deferred revenue 0 25,078
Net cash used in operating activities (3,207,328) (3,230,098)
Cash flows from investing activities:    
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 7,851,626 262,459
Proceeds from short term insurance financing 175,194 181,797
Payments on short term insurance financing (85,056) (71,506)
Net cash provided by financing activities 7,941,764 372,750
Net increase (decrease) in cash and cash equivalents 4,734,436 (2,857,348)
Cash and cash equivalents and restricted cash, beginning of period 2,288,705 5,435,983
Cash and cash equivalents and restricted cash, end of period 7,023,141 2,578,635
Supplemental cash flow information:    
Cash paid for interest 3,355 3,464
Supplemental disclosures of noncash investing and financing activities    
Reclass of commitment shares against stock issuance proceeds $ 207,493 $ 0